Boston Scientific Corp ($BSX)

3 tracked superinvestors hold Boston Scientific Corp (BSX), worth $3.3B combined, led by PRIMECAP team. Smart money is accumulating BSX as of the latest 13F filings.

Current price

$47.80

Medical - DevicesNYSEUS

-55.4%

1Y

Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these…

Market cap

$84.0B

P/E

23.64

Div yield

0.0%

Revenue YoY

19.9%

Analyst target

$67

Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.

Superinvestors holding

3

tracked 13F / N-PORT funds

Combined value

$3.3B

disclosed long exposure

Tier-1 conviction

0

concentrated holders

Net this quarter

+3

3 buying · 0 selling

Smart money is net accumulating BSX: 3 funds added or opened versus 0 trimming.

The smart-money take on BSX

Boston Scientific Corp (BSX) appears mainly in diversified and quant books here (3 funds, $3.3B combined) rather than in concentrated conviction portfolios — read the holders below with that in mind.

The largest position belongs to PRIMECAP team at 1.4% of their book — no single tracked manager treats it as an outsized, top-weighted bet.

No tracked fund opened a new position this quarter; 3 added and 0 trimmed, a net add.

Superinvestors holding BSX

InvestorMove% of their portfolioPosition value
3
PRIMECAP team

Vanguard PRIMECAP

Added1.4%$1.3B
2
David Shaw

D.E. Shaw

Added0.6%$1.2B
2
Added0.6%$829M

Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.

Frequently asked

Which superinvestors own BSX?

3 tracked funds hold Boston Scientific Corp (BSX), the largest being PRIMECAP team (Vanguard PRIMECAP) at 1.4% of its 13F portfolio. 0 of them are concentrated Tier-1 conviction managers.

Is smart money buying or selling BSX?

In the most recent 13F quarter, 3 tracked funds added or opened BSX and 0 trimmed it.

How much BSX do tracked funds hold?

Combined disclosed long exposure to BSX across tracked superinvestors is $3.3B as of the Jun 2026 filings.

Stocks often held alongside BSX

Get alerted when superinvestors trade $BSX

One email when a tracked manager opens, adds to or files to sell a position — from Form 4, 13D and Form 144, not the 45-day-old 13F.

Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Jun 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.